Skip to main content
Log in

Low levels of serum vitronectin associated with clinical phases in patients with hemorrhagic fever with renal syndrome

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

β3 integrin has been identified as a cellular receptor for Hantaan virus which causes hemorrhagic fever with renal syndrome (HFRS). As one of the ligands of β3 integrin, vitronectin (VN) may be altered in HFRS. In this study, changes of serum VN levels were determined in 112 patients with HFRS and 30 age- and sex-matched healthy controls by quantitative sandwich enzyme immunoassay. The levels of serum VN were analyzed in patients at various phases of HFRS and with different severity of clinical types. Serum VN levels in patients with HFRS, at all clinical phases except the convalescent phase, were significantly decreased compared with those in the controls (P < 0.01). The serum levels of VN decreased at febrile phase, maintained at the lowest status during hypotensive and oliguric phases, started to increase from polyuric phase and reached almost normal condition till convalescent phase. The levels of serum VN between patients with milder and more severe clinical types showed no significant difference at each phase (P > 0.05). These results suggest that VN level was altered during the course of HFRS and chronological changes of serum levels of VN may correlate with the evolution of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lee HW (1982) Hemorrhagic fever with renal syndrome (HFRS). Scand J Infect Dis 36:S82–S85

    Google Scholar 

  2. World Health Organization (1983) Haemorrhagic fever with renal syndrome: memorandum from a WHO meeting. Bull WHO 61:269–275

    Google Scholar 

  3. Faulde M, Sobe D, Kimmig P, Scharninghausen J (2000) Renal failure and hantavirus infection in Europe. Nephrol Dial Transplant 15:751–753

    Article  PubMed  CAS  Google Scholar 

  4. Cosgriff TM (1991) Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis 13:97–107

    PubMed  CAS  Google Scholar 

  5. Schmaljohn C, Hjelle B (1997) Hantaviruses: a global disease problem. Emerg Infect Dis 3:95–104

    Article  PubMed  CAS  Google Scholar 

  6. Reynolds LE, Wyder L, Lively JC et al (2002) Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8:27–34

    Article  PubMed  CAS  Google Scholar 

  7. Martinez-Lemus LA, Wu X, Wilson E et al (2003) Integrins as unique receptors for vascular control. J Vasc Res 40:211–233

    Article  PubMed  CAS  Google Scholar 

  8. Sonnenberg A (1993) Integrin and their ligands. Curr Top Microbiol Immun 184:7–35

    CAS  Google Scholar 

  9. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER (1999) Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 73:3951–3959

    PubMed  CAS  Google Scholar 

  10. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER (2002) Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci USA 99:13837–13842

    Article  PubMed  CAS  Google Scholar 

  11. Mackow ER, Gavrilovskaya IN (2001) Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 256:91–115

    PubMed  CAS  Google Scholar 

  12. Liu Z, Gao M, Han Q, Fang J, Zhao Q, Zhang N (2008) Intensity of platelet β3 integrin in patients with hemorrhagic fever with renal syndrome and its correlation with disease severity. Viral Immunol 21:255–261

    Article  PubMed  CAS  Google Scholar 

  13. Liang M, Li D, Xiao SY, Hang C, Rossi CA, Schmaljohn CS (1994) Antigenic and molecular characterization of hantavirus isolates from China. Virus Res 31:219–233

    Article  PubMed  CAS  Google Scholar 

  14. Liu Z, Zhao Q, Han Q, Gao M, Zhang N (2008) Serum thrombospondin-1 is altered in patients with hemorrhagic fever with renal syndrome. J Med Virol 80:1799–1803

    Article  PubMed  CAS  Google Scholar 

  15. Lee HW, Lee PW, Johnson KM (1978) Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis 137:298–308

    PubMed  CAS  Google Scholar 

  16. Seiffert D, Schleef RR (1996) Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules. Blood 88:552–560

    PubMed  CAS  Google Scholar 

  17. Takala A, Lähdevirta J, Jansson SE et al (2000) Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury. J Infect Dis 181:1964–1970

    Article  PubMed  CAS  Google Scholar 

  18. Høgåsen K, Mollnes TE, Brandtzaeg P (1994) Low levels of vitronectin and clusterin in acute meningococcal disease are closely associated with formation of the terminal-complement complex and the vitronectin-thrombin-antithrombin complex. Infect Immun 62:4874–4880

    PubMed  Google Scholar 

  19. Korc-Grodzicki B, Tauber-Finkelstein M, Chain D, Shaltiel S (1988) Vitronectin is phosphorylated by a cAMP-dependent protein kinase released by activation of human platelets with thrombin. Biochem Biophys Res Commun 157:1131–1138

    Article  PubMed  CAS  Google Scholar 

  20. Preissner KT, Anders E, Grulich-Henn J, Müller-Berghaus G (1988) Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. Blood 71:1581–1589

    PubMed  CAS  Google Scholar 

  21. de Boer HC, Preissner KT, Bouma BN, de Groot PG (1992) Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. J Biol Chem 267:2264–2268

    PubMed  Google Scholar 

  22. Sirotin BZ, Fedorchenko YL (1996) Visualization of microcirculatory disorders in haemorrhagic fever with renal syndrome. Nephrol Dial Transplant 11:721–722

    PubMed  CAS  Google Scholar 

  23. Hjelle B, Jenison SA, Goade DE, Green WB, Feddersen RM, Scott AA (1995) Hantaviruses: clinical, microbiologic, and epidemiologic aspects. Crit Rev Clin Lab Sci 32:469–508

    Article  PubMed  CAS  Google Scholar 

  24. Reheman A, Gross P, Yang H et al (2005) Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 3:875–883

    Article  PubMed  CAS  Google Scholar 

  25. Conlan MG, Tomasini BR, Schultz RL, Mosher DF (1988) Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. Blood 72:185–190

    PubMed  CAS  Google Scholar 

  26. Kemkes-Matthes B, Preissner KT, Langenscheidt F, Matthes KJ, Müller-Berghaus G (1987) S protein/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3. Eur J Haematol 39:161–165

    Article  PubMed  CAS  Google Scholar 

  27. Kobayashi J, Yamada S, Kawasaki H (1994) Distribution of vitronectin in plasma and liver tissue: relationship to chronic liver disease. Hepatology 20:1412–1417

    Article  PubMed  CAS  Google Scholar 

  28. Inuzuka S, Ueno T, Torimura T et al (1992) Vitronectin in liver disorders: biochemical and immunohistochemical studies. Hepatology 15:629–636

    Article  PubMed  CAS  Google Scholar 

  29. Yamada S, Suou T, Kawasaki H (1997) Plasma vitronectin concentrations in patients with chronic hepatitis C treated with interferon alpha. Clin Chim Acta 261:81–90

    Article  PubMed  CAS  Google Scholar 

  30. Sun HC, Deng PF, Wang CJ et al (1997) Liver involvement in epidemic haemorrhagic fever: in situ hybridization, immunohistochemical and pathological studies. J Gastroenterol Hepatol 12:540–546

    Article  PubMed  CAS  Google Scholar 

  31. Elisaf M, Stefanaki S, Repanti M, Korakis H, Tsianos E, Siamopoulos KC (1993) Liver involvement in hemorrhagic fever with renal syndrome. J Clin Gastroenterol 17:33–37

    Article  PubMed  CAS  Google Scholar 

  32. Morioka S, Makino H, Shikata K, Ota Z (1994) Changes in plasma concentrations of vitronectin in patients with diabetic nephropathy. Acta Med Okayama 48:137–142

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of the People’s Republic of China (No. 30271176), and Provincial Science and Technological Program of Shaanxi Province, China (2004K172G8). We are indebted to Miss Jian Chen in the Department of Medical Affairs, First Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, for her helpful work in the manuscript preparation.

Conflict of interest statement

The authors declare that they have no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhengwen Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, Z., Han, Q., Zhang, L. et al. Low levels of serum vitronectin associated with clinical phases in patients with hemorrhagic fever with renal syndrome. Clin Exp Med 9, 297–301 (2009). https://doi.org/10.1007/s10238-009-0050-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-009-0050-4

Keywords

Navigation